Medexus Pharmaceuticals Inc
TSX:MDP
Medexus Pharmaceuticals Inc
Operating Income
Medexus Pharmaceuticals Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medexus Pharmaceuticals Inc
TSX:MDP
|
Operating Income
$12.8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Income
-CA$337.4m
|
CAGR 3-Years
25%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Operating Income
-$79.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Operating Income
$12.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Operating Income
-$23.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Medexus Pharmaceuticals Inc's Operating Income?
Operating Income
12.8m
USD
Based on the financial report for Dec 31, 2023, Medexus Pharmaceuticals Inc's Operating Income amounts to 12.8m USD.
What is Medexus Pharmaceuticals Inc's Operating Income growth rate?
Operating Income CAGR 3Y
26%
Over the last year, the Operating Income growth was 194%. The average annual Operating Income growth rates for Medexus Pharmaceuticals Inc have been 26% over the past three years .